Estimating the sample size required to detect an arterial spin labelling magnetic resonance imaging perfusion abnormality in voxel-wise group analyses

Journal of Neuroscience Methods
Anna M MersovBradley J MacIntosh

Abstract

Voxel-based analyses are pervasive across the range of neuroimaging techniques. In the case of perfusion imaging using arterial spin labelling (ASL), a low signal-to-noise technique, there is a tradeoff between the contrast-to-noise required to detect a perfusion abnormality and its spatial localisation. In exploratory studies, the use of an a priori region of interest (ROI), which has the benefit of averaging multiple voxels, may not be justified. Thus the question considered in this study pertains to the sample size that is required to detect a voxel-level perfusion difference between groups and two algorithms are considered. Empirical 3T ASL data were acquired from 25 older adults and simulations were performed based on the group template cerebral blood flow (CBF) images. General linear model (GLM) and permutation-based algorithms were tested for their ability to detect a predefined hypoperfused ROI. Simulation parameters included: inter and intra-subject variability, degree of hypoperfusion and sample size. The true positive rate was used as a measure of sensitivity. For a modest group perfusion difference, i.e., 10%, 37 participants per group were required when using the permutation-based algorithm, whereas 20 participants...Continue Reading

References

Dec 18, 2001·Human Brain Mapping·Thomas E Nichols, Andrew P Holmes
Sep 3, 2002·Journal of Neuroscience Methods·John E Desmond, Gary H Glover
Mar 31, 2004·NeuroImage·Mark W WoolrichStephen M Smith
Apr 6, 2004·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Laura M ParkesPaul S Tofts
Sep 28, 2007·IEEE Transactions on Medical Imaging·Hua Li, Anthony Yezzi
Oct 26, 2007·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Iris AsllaniYaakov Stern
May 29, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Bradley J MacIntoshPeter Jezzard
Dec 9, 2008·NeuroImage·Mark W WoolrichStephen M Smith
Apr 14, 2009·Topics in Magnetic Resonance Imaging : TMRI·Jean Théberge
Apr 15, 2009·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Matthias J P van OschMark A van Buchem
Apr 24, 2009·Journal of Magnetic Resonance Imaging : JMRI·Huan TanRobert A Kraft
Aug 8, 2009·NeuroImage·Esben Thade PetersenUNKNOWN all named co-authors of the QUASAR test-retest study
Aug 8, 2009·Neurobiology of Aging·Susan M LandauUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 11, 2010·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Bradley J MacIntoshPeter Jezzard
Feb 27, 2010·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Sina AslanHanzhang Lu
Mar 11, 2010·Journal of the American Academy of Child and Adolescent Psychiatry·Kathryn R CullenKelvin O Lim
Mar 12, 2010·Alzheimer Disease and Associated Disorders·Linda L ChaoMichael W Weiner
Apr 29, 2010·Magnetic Resonance Imaging·Sina Aslan, Hanzhang Lu
Jun 15, 2010·Cerebral Cortex·Dietsje D JollesSerge A R B Rombouts
Jul 22, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ajna BorogovacIris Asllani
Jan 25, 2011·NeuroImage·Florian BeissnerSimon Baudrexel
Feb 12, 2011·Brain : a Journal of Neurology·Tracy R MelzerTim J Anderson
Oct 29, 2011·NeuroImage·María A Fernández-SearaMaría A Pastor
Aug 8, 2013·NeuroImage·Theodore D SatterthwaiteRaquel E Gur
Mar 13, 2014·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Campbell J Le HeronTim J Anderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.